Does neoadjuvant therapy contribute to increased risk in anastomotic leakage of esophageal cancer? A network meta‐analysis
Neoadjuvant therapy do not significantly increase the incidence of AL after esophagectomy. Administration of irradiation with a moderate dose is not associated with elevated risk in AL. Clinicians can be less apprehensive about prescribing nCRT.
Authors
- Rongying Zhu
- Donglai Chen (ORCID: https://orcid.org/0000-0001-7603-4803)
- Sukai Xu
- Zihao Hu (ORCID: https://orcid.org/0009-0006-1465-7080)
- Yongbing Chen (ORCID: https://orcid.org/0000-0002-7595-092X)
- Da Zhou
- Peidong Song
Institutions
- Sun Yat-sen University (CN)
- Fudan University (CN)
- Soochow University (CN)
- Second Affiliated Hospital of Soochow University (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- Journal of Evidence-Based Medicine
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1111/jebm.12634
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Jiangsu Commission of Health
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Soochow University
- Second Affiliated Hospital of Soochow University